Filtered By:
Specialty: Hospital Management

This page shows you your search results in order of relevance. This is page number 6.

Order by Relevance | Date

Total 178 results found since Jan 2013.

DES reduce the risk of ISR in patients with ICAS compared to BMS
Dr. Snipe Clinical question: In patients with symptomatic high-grade intracranial atherosclerotic stenosis (ICAS), does the use of a drug-eluting stent (DES) reduce the incidence of in-stent restenosis (ISR) and stroke recurrence compared to using a bare-metal stent (BMS)? Background: ICAS is a common cause of stroke in North America (accounting for 8-10% of strokes) and is even more common in Asia (accounting for 30-50% of strokes). In previous trials, aggressive medical management was found to be the superior first-line treatment, but intracranial stenting is growing in popularity and safety. DES is known to reduce ISR ...
Source: The Hospitalist - August 1, 2022 Category: Hospital Management Authors: Ronda Whitaker Tags: CAD & Atherosclerosis Critical Care In the Literature Source Type: research

Anticoagulant choice in antiphospholipid syndrome – associated thrombosis
Background: DOACs have largely replaced VKAs as first-line therapy for venous thromboembolism in patients with adequate renal function. However, there is concern in APS that DOACs may have higher rates of recurrent thrombosis than VKAs when treating thromboembolism. Dr. David Portnoy Study design: Randomized noninferiority trial. Setting: Six teaching hospitals in Spain. Synopsis: Of adults with thrombotic APS, 190 were randomized to receive rivaroxaban or warfarin. Primary outcomes were thrombotic events and major bleeding. Follow-up after 3 years demonstrated new thromboses in 11 patients (11.6%) in the DOAC...
Source: The Hospitalist - December 10, 2021 Category: Hospital Management Authors: Daniel Hickman Tags: Hematology Thrombosis Source Type: research

There is a Decreased Risk of Hospitalization from Heart Failure in Type II Diabetics Initiated on a SGLT2 Inhibitor When Compared to a GLP-1 Receptor Agonist
Dr. Huang Clinical question: Determine the cardiovascular risk outcome in type II diabetic patients initiated on an sodium-glucose cotransporter-2 (SGLT2)  inhibitor versus a glucagon-like peptide-1 (GLP-1) receptor agonist. Background: Various studies have suggested that several SGLT2 inhibitors and GLP-1 receptor agonists may improve cardiac outcomes—myocardial infarction, stroke, hospitalization for heart failure, and cardiovascular death. Current guidelines recommend using either an SGLT2 inhibitor or GLP-1 receptor agonist for patients with type II diabetes and cardiovascular disease. However, there has been no st...
Source: The Hospitalist - September 1, 2022 Category: Hospital Management Authors: Ronda Whitaker Tags: Diabetes Heart Failure In the Literature Source Type: research

From lift off to splash down: An update on Mayo Clinic stem cells in space
It's been six years since Mayo Clinic physician Abba Zubair, M.D., Ph.D., watched stem cells from his regenerative medicine laboratory blast into space as part of a research effort to see if zero gravity would help the cells multiply faster. Approximately 15 million people worldwide experience a stroke annually, according to the World Health Organization. Currently, stroke remains a top cause of death and disability in the world. Finding new therapies for stroke is important…
Source: Mayo Clinic Florida News - May 26, 2023 Category: Hospital Management Source Type: news

Telestroke program extends critical care to patients in rural and regional areas
UT Southwestern Medical Center has launched a state-of-the-art telemedicine program that will extend immediate access to UTSW’s nationally recognized stroke care during the crucial time period when treatment is needed for an ischemic stroke.
Source: UT Southwestern Medical Center News - March 31, 2014 Category: Hospital Management Source Type: news

UPMC East prepares to open hospital rehab unit
UPMC East Hospital in Monroeville is preparing to open a 19-bed rehabilitation unit, the ninth in the hospital network, with media tours scheduled Wednesday. The unit is UPMC’s first in the eastern suburbs. Services will include specialized physical, occupational and speech therapy for people who have suffered stroke, traumatic injuries and other medical problems. The Joint Commission accredited UPMC East as a primary stroke center and the hospital’s application is pending at the state Department…
Source: bizjournals.com Health Care:Hospitals headlines - June 25, 2014 Category: Hospital Management Authors: Kris B. Mamula Source Type: research

St. Michael’s stroke patients benefitting from My Stroke Passport resource guide
Source: St. Michael's Hospital News and Media - August 16, 2014 Category: Hospital Management Tags: Hospital News Source Type: news

MRIGlobal wins $54M NIH contract
The National Institute of Neurological Disorders and Stroke has awarded a $54 million contract to Kansas City-based MRIGlobal. The money will support a 10-year program through NINDS, a division of the National Institutes of Health. The project will involve drug product manufacturing, packaging and labeling; stability studies; and drug storage and distribution for clinical trials. "Neurological disorders and stroke impact hundreds of millions of people worldwide," MRIGlobal CEO Thomas Sack said…
Source: bizjournals.com Health Care:Hospitals headlines - January 15, 2015 Category: Hospital Management Authors: Brianne Pfannenstiel Source Type: news

Updates in perioperative medicine
CONCLUSIONSThe body of literature reviewed provides important information for clinicians caring for surgical patients across multiple fronts, including preoperative risk assessment, medication management, and postoperative medical care. Journal of Hospital Medicine 2015. © 2015 Society of Hospital Medicine
Source: Journal of Hospital Medicine - September 18, 2015 Category: Hospital Management Authors: Suparna Dutta, Steven L. Cohn, Kurt J. Pfeifer, Barbara A. Slawski, Gerald W. Smetana, Amir K. Jaffer Tags: Reviews Source Type: research

Readmissions following hospitalisations for cardiovascular disease: a scoping review of the Australian literature.
ConclusionsHigh rates of readmissions are reported for cardiovascular conditions, although substantial methodological heterogeneity exists among studies. Nationally standardised definitions are required to accurately measure readmissions and further studies are needed to address knowledge gaps and test interventions to lower readmissions in Australia.What is known about the topic?International studies suggest readmissions are common following cardiovascular hospitalisations and are costly to the health system, yet little is known about the burden of readmission in the Australian setting or the effectiveness of intervention...
Source: Australian Health Review - February 20, 2019 Category: Hospital Management Authors: Labrosciano C, Air T, Tavella R, Beltrame JF, Ranasinghe I Tags: Aust Health Rev Source Type: research

What Medications Prevent Delirium in Elderly Medical Inpatients?
This study demonstrated lower rates of delirium in the melatonin arm, with an impressive number needed to treat (NNT) below six patients; mortality and length of hospital stay were unaffected.3 A delirium-prevention effect of melatonin has not been reproduced in other studies, notably Jaiswal et al, which randomized patients to a placebo or 3 mg of melatonin and found no difference in rates of delirium prevention.7  The melatonin receptor agonist ramelteon also has small but favorable evidence for preventing non-ICU hospitalized delirium. This comes from a study of 67 patients aged 65 years or older who were randomized to...
Source: The Hospitalist - May 2, 2022 Category: Hospital Management Authors: Ronda Whitaker Tags: Drug Therapy Geriatrics Key Clinical Questions Medication Source Type: research

Evolution of non-fatal burden estimates for cardiovascular disease in Australia: a comparison of national and state-wide methodology of burden of disease
ConclusionsPrevalence estimates require the best available data sources, updated disease models and constant review to inform government policy and health reform. Availability of nation-wide linked data will markedly improve future burden estimates.PMID:36395787 | DOI:10.1071/AH22149
Source: Australian Health Review - November 17, 2022 Category: Hospital Management Authors: Courtney Weber Michelle Hobday Wendy Sun Laura Kirkland Lee Nedkoff Judith M Katzenellenbogen Source Type: research